You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Exercise Disclosure
Sloan Sheldon · SEC Form 4 · Filed Jun 3, 2026
Exercise
Calculated transaction value
$0
Sloan Sheldon Chief Medical Officer
SYRE
Spyre Therapeutics
SYRE
Transaction date
Jun 3, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed same day
SYRE daily price context
Close on/before transaction
$73.52
Jun 3, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 8,333 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001636282-26-000078
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$853.8K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE | Exercise | Jun 3, 2026 | $228.82K |
| Spyre Therapeutics, Inc. SYRE | Sale | Jun 3, 2026 | $624.98K |
| Spyre Therapeutics, Inc. SYRE Current | Exercise | Jun 3, 2026 | $0 |